, Byung-Su Kim2
, Jeong-Wook Park3
, Jong-Hee Sohn4
, Mi Ji Lee5
, Byung-Kun Kim6
, Min Kyung Chu7
, Tae-Jin Song8
, Soo-Kyoung Kim9
, Heui-Soo Moon1
, Kyungmi Oh10
, Soo-Jin Cho11
1Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
2Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea
3Department of Neurology, Uijeongbu St. Mary’s Hospital, Uijeongbu, Republic of Korea
4Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea
5Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
6Department of Neurology, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea
7Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
8Department of Neurology, Ewha Womans University School of Medicine, Seoul, Republic of Korea
9Department of Neurology, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
10Department of Neurology, Korea University College of Medicine, Seoul, Republic of Korea
11Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea
© 2026 The Korean Headache Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
AVAILABILITY OF DATA AND MATERIAL
The data presented in this study are available upon reasonable request from the corresponding author.
AUTHOR CONTRIBUTIONS
Conceptualization: PWC, BSK, SJC; Data curation: PWC, BSK, MJL, BKK, MKC, TJS, SKK, HSM, KO, SJC; Formal analysis: BSK, JWP; Investigation: PWC, JHS, TJS, SJC; Methodology: BSK, HSM, KO; Writing–original draft: PWC, SJC; Writing–review & editing: BSK, JWP, JHS, MJL, BKK, MKC, TJS, SKK, HSM, KO, SJC.
CONFLICT OF INTEREST
Soo-Kyoung Kim is the Deputy Editor of Headache and Pain Research and was not involved in the review process of this article.
Kyungmi Oh is the Associate Editor of Headache and Pain Research and was not involved in the review process of this article.
Soo-Jin Cho is the Editor-in-Chief of Headache and Pain Research and was not involved in the review process of this article.
All authors have no other conflicts of interest to declare.
FUNDING STATEMENT
Not applicable.
ACKNOWLEDGMENTS
Not applicable.
| All patients (n=337) | Pediatric-onset (n=83)† | Adult-onset (n=254)† | p-value | |
|---|---|---|---|---|
| Age (yr) | 37.0±9.8 | 29.6±7.4 | 39.4±9.2 | <0.001 |
| Female sex | 55 (16.3) | 15 (18.1) | 40 (15.8) | 0.619 |
| Current smoker | 151 (44.8) | 23 (27.7) | 128 (50.4) | <0.001 |
| Ever-smoker* | 204 (60.5) | 34 (41.0) | 170 (66.9) | <0.001 |
| Alcohol drinking | 213 (63.2) | 46 (55.4) | 167 (65.7) | 0.09 |
| Coexisting migraine | 44 (13.1) | 10 (12.0) | 34 (13.4) | 0.754 |
| All patients (n=337) | Pediatric-onset (n=83)* | Adult-onset (n=254)* | p-value | |
|---|---|---|---|---|
| Onset age of CH disease (yr) | 26.1±9.9 | 15.7±2.4 | 29.5±9.1 | <0.001 |
| Duration of CH disease (yr) | 10.9±7.2 | 13.9±7.6 | 9.9±6.8 | <0.001 |
| Diagnostic delay (yr) | 7.2±6.9 | 10.1±7.6 | 6.2±6.5 | <0.001 |
| Lifetime bout occurrence (n) | 9.7±10.8 | 14.9±17.6 | 8.0±6.5 | <0.001 |
| Bout frequency (times/yr) | 1.1±2.3 | 1.2±1.4 | 1.1±2.5 | 0.864 |
| All patients (n=337) | Pediatric-onset (n=83)* | Adult-onset (n=254)* | p-value | |
|---|---|---|---|---|
| CH characteristics | ||||
| Attack severity (0–10 NRS) | 9.0±1.2 | 9.2±0.9 | 8.9±1.3 | 0.025 |
| Attack frequency (times/day) | 2.0±2.1 | 1.7±1.3 | 2.1±2.2 | 0.108 |
| Attack duration (min) | 96.2±56.4 | 101.4±47.1 | 94.5±59.1 | 0.33 |
| Duration of bout (wk) | 6.2±5.3 | 6.6±7.1 | 6.1±4.6 | 0.401 |
| Diurnal rhythmicity | 209 (62.0) | 48 (57.8) | 161 (63.4) | 0.138 |
| Seasonal propensity | 182 (54.0) | 45 (54.2) | 137 (53.9) | 0.735 |
| Psychiatric status | ||||
| GAD-7 score | 8.1±6.0 | 7.5±6.1 | 8.3±6.0 | 0.292 |
| PHQ-9 score | 7.8±6.6 | 7.0±6.8 | 8.1±6.5 | 0.174 |
| Suicidal ideation | 79 (23.4) | 22 (26.5) | 57 (22.4) | 0.747 |
| Suicide attempt | 3 (0.9) | 1 (1.2) | 2 (0.8) | 0.757 |
| HIT-6 score | 69.4±7.8 | 70.1±7.0 | 69.1±8.0 | 0.322 |
Values are presented as mean±standard deviation or number (%).
CH, cluster headache; NRS, numerical rating scale; GAD-7, 7-item Generalized Anxiety Disorder scale; PHQ-9, 9-item Patient Health Questionnaire scale; HIT-6, 6-item Headache Impact Test.
*Pediatric-onset was defined as onset age 18 years or less, and adult-onset was defined as onset age more than 18 years.
PubReader
ePub Link
Cite this Article
| All patients (n=337) | Pediatric-onset (n=83) |
Adult-onset (n=254) |
p-value | |
|---|---|---|---|---|
| Age (yr) | 37.0±9.8 | 29.6±7.4 | 39.4±9.2 | <0.001 |
| Female sex | 55 (16.3) | 15 (18.1) | 40 (15.8) | 0.619 |
| Current smoker | 151 (44.8) | 23 (27.7) | 128 (50.4) | <0.001 |
| Ever-smoker |
204 (60.5) | 34 (41.0) | 170 (66.9) | <0.001 |
| Alcohol drinking | 213 (63.2) | 46 (55.4) | 167 (65.7) | 0.09 |
| Coexisting migraine | 44 (13.1) | 10 (12.0) | 34 (13.4) | 0.754 |
| All patients (n=337) | Pediatric-onset (n=83) |
Adult-onset (n=254) |
p-value | |
|---|---|---|---|---|
| Onset age of CH disease (yr) | 26.1±9.9 | 15.7±2.4 | 29.5±9.1 | <0.001 |
| Duration of CH disease (yr) | 10.9±7.2 | 13.9±7.6 | 9.9±6.8 | <0.001 |
| Diagnostic delay (yr) | 7.2±6.9 | 10.1±7.6 | 6.2±6.5 | <0.001 |
| Lifetime bout occurrence (n) | 9.7±10.8 | 14.9±17.6 | 8.0±6.5 | <0.001 |
| Bout frequency (times/yr) | 1.1±2.3 | 1.2±1.4 | 1.1±2.5 | 0.864 |
| All patients (n=337) | Pediatric-onset (n=83) |
Adult-onset (n=254) |
p-value | |
|---|---|---|---|---|
| CH characteristics | ||||
| Attack severity (0–10 NRS) | 9.0±1.2 | 9.2±0.9 | 8.9±1.3 | 0.025 |
| Attack frequency (times/day) | 2.0±2.1 | 1.7±1.3 | 2.1±2.2 | 0.108 |
| Attack duration (min) | 96.2±56.4 | 101.4±47.1 | 94.5±59.1 | 0.33 |
| Duration of bout (wk) | 6.2±5.3 | 6.6±7.1 | 6.1±4.6 | 0.401 |
| Diurnal rhythmicity | 209 (62.0) | 48 (57.8) | 161 (63.4) | 0.138 |
| Seasonal propensity | 182 (54.0) | 45 (54.2) | 137 (53.9) | 0.735 |
| Psychiatric status | ||||
| GAD-7 score | 8.1±6.0 | 7.5±6.1 | 8.3±6.0 | 0.292 |
| PHQ-9 score | 7.8±6.6 | 7.0±6.8 | 8.1±6.5 | 0.174 |
| Suicidal ideation | 79 (23.4) | 22 (26.5) | 57 (22.4) | 0.747 |
| Suicide attempt | 3 (0.9) | 1 (1.2) | 2 (0.8) | 0.757 |
| HIT-6 score | 69.4±7.8 | 70.1±7.0 | 69.1±8.0 | 0.322 |
Values are presented as mean±standard deviation or number (%). *Ever-smokers, current and ex-smokers combined; †Pediatric-onset was defined as onset age 18 years or less, and adult-onset was defined as onset age more than 18 years.
Values are presented as mean±standard deviation. CH, cluster headache. Pediatric-onset was defined as onset age 18 years or less, and adult-onset was defined as onset age more than 18 years.
Values are presented as mean±standard deviation or number (%). CH, cluster headache; NRS, numerical rating scale; GAD-7, 7-item Generalized Anxiety Disorder scale; PHQ-9, 9-item Patient Health Questionnaire scale; HIT-6, 6-item Headache Impact Test. Pediatric-onset was defined as onset age 18 years or less, and adult-onset was defined as onset age more than 18 years.